NO20081529L - Naftyridinderivater - Google Patents
NaftyridinderivaterInfo
- Publication number
- NO20081529L NO20081529L NO20081529A NO20081529A NO20081529L NO 20081529 L NO20081529 L NO 20081529L NO 20081529 A NO20081529 A NO 20081529A NO 20081529 A NO20081529 A NO 20081529A NO 20081529 L NO20081529 L NO 20081529L
- Authority
- NO
- Norway
- Prior art keywords
- naphthyridine
- antagonists
- compounds
- general formula
- relates
- Prior art date
Links
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 title 1
- 102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 abstract 1
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05109241 | 2005-10-05 | ||
| PCT/EP2006/066709 WO2007039512A1 (en) | 2005-10-05 | 2006-09-25 | Naphthyridin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081529L true NO20081529L (no) | 2008-06-18 |
Family
ID=37603335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081529A NO20081529L (no) | 2005-10-05 | 2008-03-28 | Naftyridinderivater |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7511055B2 (de) |
| EP (1) | EP1934216B1 (de) |
| JP (1) | JP4870164B2 (de) |
| KR (1) | KR101020319B1 (de) |
| CN (1) | CN101277958B (de) |
| AR (1) | AR055675A1 (de) |
| AT (1) | ATE489386T1 (de) |
| AU (1) | AU2006298727B2 (de) |
| BR (1) | BRPI0616865A2 (de) |
| CA (1) | CA2624413A1 (de) |
| DE (1) | DE602006018496D1 (de) |
| ES (1) | ES2354627T3 (de) |
| IL (1) | IL190222A (de) |
| NO (1) | NO20081529L (de) |
| RU (1) | RU2418799C2 (de) |
| TW (1) | TWI340746B (de) |
| WO (1) | WO2007039512A1 (de) |
| ZA (1) | ZA200802989B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006011752D1 (de) * | 2005-06-24 | 2010-03-04 | Bristol Myers Squibb Co | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate |
| TWI529171B (zh) * | 2013-07-29 | 2016-04-11 | 赫孚孟拉羅股份公司 | １，７－萘啶衍生物 |
| JP7644009B2 (ja) | 2018-12-21 | 2025-03-11 | オゲダ エス．エー． | ３－メチル－１，２，４－チアジアゾール－５－カルボヒドラジドまたはそのメチル－ｄ３重水素化形態の合成 |
| WO2023081800A1 (en) * | 2021-11-05 | 2023-05-11 | The Regents Of The University Of California | Alpha-2a adrenergic receptor modulators and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6230780A (ja) * | 1985-04-17 | 1987-02-09 | Ss Pharmaceut Co Ltd | １，７−ナフチリジン誘導体及びこれを含有する薬剤 |
| RU2174123C2 (ru) * | 1996-10-28 | 2001-09-27 | Новартис Аг | Производные 8-арил-1,7-нафтиридина и фармацевтическая композиция, обладающая противовоспалительной активностью |
| CN1703403A (zh) * | 2000-10-02 | 2005-11-30 | 詹森药业有限公司 | 趋代谢的谷氨酸盐受体拮抗剂 |
| EP1881050B1 (de) | 2000-11-30 | 2013-01-09 | Canon Kabushiki Kaisha | Lumineszenzvorrichtung und Anzeigeapparat |
| ES2211344B1 (es) * | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de piridazin-3(2h)-ona. |
| BRPI0407283A (pt) | 2003-02-13 | 2006-01-31 | Banyu Pharma Co Ltd | Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade |
| WO2004076420A1 (ja) | 2003-02-26 | 2004-09-10 | Banyu Pharmaceutical Co., Ltd. | ヘテロアリールカルバモイルベンゼン誘導体 |
| EP1715867A4 (de) | 2004-02-12 | 2009-04-15 | Merck & Co Inc | Bipyridylamide als modulatoren von metabotropem glutamatrezeptor-5 |
-
2006
- 2006-09-25 BR BRPI0616865-5A patent/BRPI0616865A2/pt not_active IP Right Cessation
- 2006-09-25 EP EP06793815A patent/EP1934216B1/de not_active Not-in-force
- 2006-09-25 WO PCT/EP2006/066709 patent/WO2007039512A1/en not_active Ceased
- 2006-09-25 ES ES06793815T patent/ES2354627T3/es active Active
- 2006-09-25 AU AU2006298727A patent/AU2006298727B2/en not_active Ceased
- 2006-09-25 DE DE602006018496T patent/DE602006018496D1/de active Active
- 2006-09-25 CA CA002624413A patent/CA2624413A1/en not_active Abandoned
- 2006-09-25 KR KR1020087010694A patent/KR101020319B1/ko not_active Expired - Fee Related
- 2006-09-25 JP JP2008533971A patent/JP4870164B2/ja not_active Expired - Fee Related
- 2006-09-25 AT AT06793815T patent/ATE489386T1/de active
- 2006-09-25 RU RU2008111565/04A patent/RU2418799C2/ru not_active IP Right Cessation
- 2006-09-25 CN CN2006800366740A patent/CN101277958B/zh not_active Expired - Fee Related
- 2006-09-28 US US11/529,992 patent/US7511055B2/en not_active Expired - Fee Related
- 2006-10-02 TW TW095136605A patent/TWI340746B/zh not_active IP Right Cessation
- 2006-10-03 AR ARP060104341A patent/AR055675A1/es not_active Application Discontinuation
-
2008
- 2008-03-17 IL IL190222A patent/IL190222A/en not_active IP Right Cessation
- 2008-03-28 NO NO20081529A patent/NO20081529L/no not_active Application Discontinuation
- 2008-04-04 ZA ZA200802989A patent/ZA200802989B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL190222A0 (en) | 2008-11-03 |
| EP1934216A1 (de) | 2008-06-25 |
| CA2624413A1 (en) | 2007-04-12 |
| RU2008111565A (ru) | 2009-11-10 |
| AU2006298727A1 (en) | 2007-04-12 |
| DE602006018496D1 (de) | 2011-01-05 |
| KR101020319B1 (ko) | 2011-03-08 |
| AU2006298727B2 (en) | 2011-11-17 |
| WO2007039512A1 (en) | 2007-04-12 |
| US20070078155A1 (en) | 2007-04-05 |
| CN101277958B (zh) | 2011-09-07 |
| IL190222A (en) | 2011-11-30 |
| TW200745110A (en) | 2007-12-16 |
| KR20080054436A (ko) | 2008-06-17 |
| ES2354627T3 (es) | 2011-03-16 |
| BRPI0616865A2 (pt) | 2011-07-05 |
| ATE489386T1 (de) | 2010-12-15 |
| EP1934216B1 (de) | 2010-11-24 |
| TWI340746B (en) | 2011-04-21 |
| US7511055B2 (en) | 2009-03-31 |
| JP4870164B2 (ja) | 2012-02-08 |
| RU2418799C2 (ru) | 2011-05-20 |
| JP2009511443A (ja) | 2009-03-19 |
| AR055675A1 (es) | 2007-08-29 |
| CN101277958A (zh) | 2008-10-01 |
| ZA200802989B (en) | 2009-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073663L (no) | Tiazol-4-karboksamid-derivater som mGluR5 antagonister | |
| NO20083582L (no) | Pyridin-2-karboksamide derivater | |
| NO20074287L (no) | Pyrazin-2-karboksamidderivater som mGluR5 antagonister | |
| NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
| NO20093200L (no) | Tiazolidinderivater | |
| NO20082136L (no) | 1,5-substituerte indol-2-yl-amidderivater | |
| ATE463495T1 (de) | Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20071593L (no) | Pyrimidinderivater | |
| ATE524466T1 (de) | 3-azabicycloä3.3.0üoktanverbindungen | |
| NO20070555L (no) | Kinazolinonderivater som parp-inhibitorer | |
| NO20091394L (no) | Pyridin-4-yl-derivater som immunmodulerende midler | |
| NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
| NO20070529L (no) | Kinazolindionderivater som parp-inhibitorer | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| NO20083584L (no) | Bensoyl-piperidin derivater som 5HT2/D3 modulatorer | |
| NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
| NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
| NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
| NO20071108L (no) | Nye 4-benzylidenpiperidinderivater | |
| DE602006007556D1 (de) | Heteroarylsulfonylstilbene als 5-ht2a-antagonisten | |
| NO20082209L (no) | Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer | |
| NO20090779L (no) | 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister | |
| ATE430744T1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |